Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

por Gujar, S A, Clements, D, Dielschneider, R, Helson, E, Marcato, P, Lee, P W K
Publicado 2014

Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling

por Dielschneider, R F, Xiao, W, Yoon, J-Y, Noh, E, Banerji, V, Li, H, Marshall, A J, Johnston, J B, Gibson, S B
Publicado 2014